Michael D. Hooven, Director at AtriCure, Inc. (ATRC), bought 1,145 shares at $7.15 ($8K) on 2012-09-11, disclosed to the SEC on 2012-09-12.
Open-market purchase of $8k ATRC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.14 | 100 | $714 | 8.7% |
| 2 | $7.15 | 301 | $2K | 26.2% |
| 3 | $7.20 | 744 | $5K | 65.1% |
| Total | $7.18 avg | 1,145 | $8K | 100% |
| Filing → |
| ATRC | SELL | 2015-04-01 | $1.5M | — | Filing → |
| ATRC | SELL | 2015-01-02 | $577K | — | Filing → |
| ATRC | BUY | 2012-09-17 | $8K | — | Filing → |